Broad-spectrum antiviral from Gilead; injected antiviral used for COVID-19, now under vaccine/treatment trial context
Outbreak of Bundibugyo Ebola is expanding in the DRC. Doses of experimental MBP134 are being provided for compassionate use and trials are being planned with WHO leadership; several vaccine candidates are advancing in development, with primeras trials expected in months.